AQST

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aquestive Therapeutics Inc

NASDAQ | AQST

5.82

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 17, 2025)

$657.60M

Market Cap

-

P/E Ratio

-0.7

EPS

$7.55

52 Week High

$2.12

52 Week Low

HEALTHCARE

Sector

AQST Chart

Recent Chart
Price Action

AQST Technicals

Tags:

AQST Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $58M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$31M
Selling General And Administrative $50M
Research And Development $20M
Operating Expenses $70M
Investment Income Net -
Net Interest Income -$13M
Interest Income $3.4M
Interest Expense $17M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $718K
Income Before Tax -$44M
Income Tax Expense -$14K
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$27M
Net Income -$44M

Revenue & Profitability

Earnings Performance

AQST Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $101M
Total Current Assets $88M
Cash And Cash Equivalents At Carrying Value $72M
Cash And Short Term Investments $72M
Inventory $6M
Current Net Receivables $7.3M
Total Non Current Assets $13M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $162M
Total Current Liabilities $19M
Current Accounts Payable $10M
Deferred Revenue -
Current Debt -
Short Term Debt $536K
Total Non Current Liabilities $143M
Capital Lease Obligations $5.5M
Long Term Debt $33M
Current Long Term Debt $26K
Long Term Debt Noncurrent -
Short Long Term Debt Total $38M
Other Current Liabilities $6.6M
Other Non Current Liabilities $23M
Total Shareholder Equity -$60M
Treasury Stock -
Retained Earnings -$363M
Common Stock $91K
Common Stock Shares Outstanding $87M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$36M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $718K
Capital Expenditures $159K
Change In Receivables -
Change In Inventory $725K
Profit Loss -
Cashflow From Investment -$159K
Cashflow From Financing $84M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$44M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $58M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$31M
Selling General And Administrative $50M
Research And Development $20M
Operating Expenses $70M
Investment Income Net -
Net Interest Income -$13M
Interest Income $3.4M
Interest Expense $17M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $718K
Income Before Tax -$44M
Income Tax Expense -$14K
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$27M
Ebitda -$27M
Net Income -$44M

AQST News

AQST Profile

Aquestive Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Aquestive Therapeutics, Inc. is a biopharmaceutical company based in Warren, New Jersey, dedicated to developing innovative therapies that address significant unmet medical needs in neurology and orphan diseases. Leveraging its proprietary technologies, the company is advancing a diverse pipeline of product candidates aimed at enhancing patient outcomes and improving access to vital medications both domestically and internationally. With a focus on strategic collaborations and patient-centered solutions, Aquestive is well-positioned to drive meaningful advancements in the pharmaceutical sector and contribute to better healthcare outcomes.

WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+30.18%
$0.28
AMIX
+59.55%
$1.16
KXIN
-9.26%
$0.27
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.87%
$0.04
ASST
-6.95%
$1.00
TSLA
+1.14%
$408.98
GLMD
+4.80%
$1.09
SOFI
-2.80%
$27.04
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
PLUG
-7.83%
$2.06
DNN
-4.03%
$2.38
ACHR
-5.78%
$7.42
BMNR
-10.00%
$30.96
CIFR
-3.81%
$14.36
ETHD
+8.89%
$5.69
DFLI
-1.27%
$0.80
F
-2.69%
$12.83
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
BYND
-5.09%
$1.02
NIO
-1.46%
$6.07
BITF
+3.05%
$2.65
ADAP
-15.14%
$0.05
AMZN
-0.93%
$232.49
IREN
-4.68%
$46.37
PLTR
-1.58%
$171.25
RIVN
-3.70%
$14.55
AAPL
-0.19%
$272.41
BURU
-14.99%
$0.21
MKDW
-18.20%
$0.16
TLRY
-4.93%
$1.02
RIG
+0.24%
$4.02
GOOGL
+3.20%
$285.26
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GPUS
-12.37%
$0.24
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
ADD
-25.47%
$0.05
HPE
-7.74%
$21.06
MSPR
+13.64%
$0.51
ASBP
-10.91%
$0.09
BAC
-2.11%
$51.49
CAN
-4.37%
$0.85
SRM
+53.27%
$10.30
WULF
+0.29%
$11.02
XPEV
-10.23%
$22.44
NOK
-0.89%
$6.67
GRAB
-1.81%
$5.31
HOOD
+0.79%
$122.50
BTG
-2.57%
$3.99
RXRX
-4.38%
$4.14
PLTD
-1.01%
$6.84
MU
-1.97%
$241.95
GOOG
+3.15%
$285.73
AMD
-3.26%
$238.76
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
IONQ
+3.92%
$47.18
HBAN
-2.73%
$15.30
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
AMC
-5.92%
$2.14
IONZ
-1.30%
$5.13
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
BTE
+0.63%
$3.16
CRWV
-2.62%
$75.33
ABEV
-0.39%
$2.54
EOSE
-5.79%
$13.00
SOUN
-6.32%
$11.40
QBTS
-5.16%
$22.39
CLF
+2.28%
$10.97
TWOH
0.00%
$0.00
AFMD
-34.94%
$0.18
CLSK
-3.42%
$10.58
T
-0.29%
$25.51
QS
-3.42%
$12.97
CORZ
-1.51%
$14.93
PCG
-0.90%
$16.34
PLTZ
+5.52%
$7.26
IVVD
+20.14%
$2.82
WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+30.18%
$0.28
AMIX
+59.55%
$1.16
KXIN
-9.26%
$0.27
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.87%
$0.04
ASST
-6.95%
$1.00
TSLA
+1.14%
$408.98
GLMD
+4.80%
$1.09
SOFI
-2.80%
$27.04
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
PLUG
-7.83%
$2.06
DNN
-4.03%
$2.38
ACHR
-5.78%
$7.42
BMNR
-10.00%
$30.96
CIFR
-3.81%
$14.36
ETHD
+8.89%
$5.69
DFLI
-1.27%
$0.80
F
-2.69%
$12.83
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
BYND
-5.09%
$1.02
NIO
-1.46%
$6.07
BITF
+3.05%
$2.65
ADAP
-15.14%
$0.05
AMZN
-0.93%
$232.49
IREN
-4.68%
$46.37
PLTR
-1.58%
$171.25
RIVN
-3.70%
$14.55
AAPL
-0.19%
$272.41
BURU
-14.99%
$0.21
MKDW
-18.20%
$0.16
TLRY
-4.93%
$1.02
RIG
+0.24%
$4.02
GOOGL
+3.20%
$285.26
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GPUS
-12.37%
$0.24
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
ADD
-25.47%
$0.05
HPE
-7.74%
$21.06
MSPR
+13.64%
$0.51
ASBP
-10.91%
$0.09
BAC
-2.11%
$51.49
CAN
-4.37%
$0.85
SRM
+53.27%
$10.30
WULF
+0.29%
$11.02
XPEV
-10.23%
$22.44
NOK
-0.89%
$6.67
GRAB
-1.81%
$5.31
HOOD
+0.79%
$122.50
BTG
-2.57%
$3.99
RXRX
-4.38%
$4.14
PLTD
-1.01%
$6.84
MU
-1.97%
$241.95
GOOG
+3.15%
$285.73
AMD
-3.26%
$238.76
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
IONQ
+3.92%
$47.18
HBAN
-2.73%
$15.30
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
AMC
-5.92%
$2.14
IONZ
-1.30%
$5.13
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
BTE
+0.63%
$3.16
CRWV
-2.62%
$75.33
ABEV
-0.39%
$2.54
EOSE
-5.79%
$13.00
SOUN
-6.32%
$11.40
QBTS
-5.16%
$22.39
CLF
+2.28%
$10.97
TWOH
0.00%
$0.00
AFMD
-34.94%
$0.18
CLSK
-3.42%
$10.58
T
-0.29%
$25.51
QS
-3.42%
$12.97
CORZ
-1.51%
$14.93
PCG
-0.90%
$16.34
PLTZ
+5.52%
$7.26
IVVD
+20.14%
$2.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.